NewLimit is a biotechnology company focusing on developing epigenetic reprogramming therapies that aid with illnesses that are normally associated with aging.
2
Funding Rounds
$170.0m
Money raised
Name | Phone | Social networks | |
---|---|---|---|
Bl*** By*** |
|
- | linkedin twitter |
The company NewLimit has raised a total of $170m in funding over 2 rounds.